Evaluation of the impact of GH treatment on primary monocytes isolated from patients experiencing inflammatory conditions, including atherosclerosis, colitis, obesity and even aging might contribute to strengthen the clinical relevance of our observations. The gene discussed is GH1; the disease is colitis.